ENDEFR
Home › Taiwan › ABBVIE BIOPHARMACEUTICALS GMBH TAIWAN BRANCH (SWITZERLAND)

ABBVIE BIOPHARMACEUTICALS GMBH TAIWAN BRANCH (SWITZERLAND)

Limited liability company (Ltd) · Taipei City, Taiwan · LEI 2549001XTJHWN2Q8Y239
LEI activebranch

Summary

ABBVIE BIOPHARMACEUTICALS GMBH TAIWAN BRANCH (SWITZERLAND) is registered in Switzerland. Its legal form is Limited liability company (Ltd). According to GLEIF, its ultimate parent is ABBVIE INC. (United States), and its direct parent is AbbVie Biopharmaceuticals GmbH (Switzerland). That group has 64 subsidiaries with LEIs in 37 countries, 1 of them in Taiwan. The LEI was first issued on 8 Jul 2021 and the record was last updated on 8 Sep 2026; the next renewal is due by 16 Sep 2027. AssetCensus found 2 data-quality notes for this entity (see below).

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

  • The ultimate-parent link rests on accounts for the period ending 31 Dec 2021, more than 24 months before this data release. The group may have changed since.
  • The ultimate-parent relationship record was not renewed; it was last updated on 18 Jan 2023.

Company details

Legal formLimited liability company (Ltd)
Register · Register website
Registration number53653958
Registration authorityMinistry of Economic Affairs
JurisdictionSwitzerland
Registered address17F. and 19F., No. 179, Liaoning St., 104 Taipei City, Taiwan
Headquarters addressAlte Steinhauserstrasse 14, 6330 Cham, Switzerland
Categorybranch
Statusactive
Founded (per GLEIF)24 Jul 2012
LEI2549001XTJHWN2Q8Y239
LEI statusactive
LEI first issued8 Jul 2021
LEI record last updated8 Sep 2026
Next LEI renewal16 Sep 2027
Corroboration of the LEI recordfully corroborated

Group membership

ABBVIE INC. United States ultimate parent
AbbVie Biopharmaceuticals GmbH Switzerland direct parent
ABBVIE BIOPHARMACEUTICALS GMBH TAIWAN BRANCH (SWITZERLAND) this entity
View the whole group: 64 subsidiaries in 37 countries

Relationship to the parent

Direct parentUltimate parent
ParentAbbVie Biopharmaceuticals GmbHABBVIE INC.
Accounting period1 Jan 2021 to 31 Dec 20211 Jan 2021 to 31 Dec 2021
Evidenceother official documentsother official documents
Corroborationsupplied by the entity onlysupplied by the entity only
Accounting standardUS GAAPUS GAAP
Consolidation percentage reported to GLEIF100.00%100.00%
Relationship start1 Jan 20131 Jan 2013
Recorded at GLEIF since8 Jul 20218 Jul 2021
Last updated18 Jan 202318 Jan 2023
Record statusnot renewednot renewed

History

15 Aug 2025Registered address changed